1 citations
,
February 2021 in “Benha Journal of Applied Sciences” This study found that ischemia-modified albumin (IMA) levels were significantly higher in patients with male pattern androgenetic alopecia compared to healthy controls, and these levels correlated with AGA duration and severity.
January 2025 in “Mansoura Medical Journal” This study examined serum ischemia-modified albumin levels in men with androgenic alopecia compared to healthy controls and found no diagnostic value, though higher levels were associated with more severe alopecia, indicating potential involvement in disease progression.
June 2024 in “Benha Journal of Applied Sciences” This study suggests that ischemia-modified albumin may play a role in premature hair graying and vasogenic erectile dysfunction, potentially serving as indicators of susceptibility and severity.
8 citations
,
May 2020 in “Anais Brasileiros de Dermatologia” This study found that serum ischemia-modified albumin levels were significantly higher in patients with telogen effluvium compared to healthy controls, suggesting a potential role of oxidative stress in the condition's pathogenesis.
January 2023 in “Mansoura Medical Journal” This study suggests that increased levels of ischemia-modified albumin, indicating oxidative stress, are associated with greater severity of acne vulgaris.